DeepMed Research

International Partnership for Microbicides, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Trial In Healthy HIV-Negative Women To Assess The Effect Of Menses And Tampon Use On The Pharmacokinetics Of Dapivirine, Delivered By Dapivirine Vaginal Ring-004, Containing 25 Mg Of Dapivirine

Phase 1

Completed

Conditions: HIV

Interventions: Drug: Dapivirine Vaginal Ring-004 and no tampons
Drug: Dapivirine Vaginal Ring-004 with tampons
Drug: Dapivirine Vaginal Ring-004 and same ring inserted after menses
Drug: Dapivirine Vaginal Ring-004 with no menses
Drug: Dapivirine Vaginal Ring-004 and new ring inserted after menses

First Posted Date: 2016-08-08

Last Posted Date: 2017-09-06

Lead Sponsor: International Partnership for Microbicides, Inc.

Target Recruit Count: 16

Registration Number: NCT02858024

PK and Safety Study of Vaginal Rings Containing Dapivirine and Levonorgestrel

Phase 1

Completed

Conditions: HIV Prevention

Interventions: Combination Product: 200 mg of DPV
Combination Product: 200 mg of DPV + 320 mg LNG

First Posted Date: 2016-08-04

Last Posted Date: 2018-05-22

Lead Sponsor: International Partnership for Microbicides, Inc.

Target Recruit Count: 24

Registration Number: NCT02855346

Locations: 🇺🇸
Magee Women's Hospital of UPMC, Pittsburgh, Pennsylvania, United States
🇺🇸
University of Alabama Hospital, Birmingham, Alabama, United States

To Assess the Drug-drug Interaction Potential Between Dapivirine Vaginal Ring-004, Containing 25 mg of Dapivirine, and Clotrimazole 10 mg/g (1%)

Phase 1

Completed

Conditions: HIV- Prevention

Interventions: Drug: Dapivirine Ring-004 for 28 days along with clotrimazole
Drug: Dapivirine Ring-004
Drug: Clotrimazole

First Posted Date: 2016-07-28

Last Posted Date: 2017-08-30

Lead Sponsor: International Partnership for Microbicides, Inc.

Target Recruit Count: 36

Registration Number: NCT02847286

Pharmacokinetic Study of the Dapivirine Vaginal Ring in Lactating Women

Phase 1

Completed

Conditions: Human Immunodeficiency Virus

Interventions: Drug: Dapivirine

First Posted Date: 2016-06-22

Last Posted Date: 2018-03-13

Lead Sponsor: International Partnership for Microbicides, Inc.

Target Recruit Count: 16

Registration Number: NCT02808949

Locations: 🇺🇸
Alabama CRS, Birmingham, Alabama, United States

Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel in HIV-1 Seronegative Adults

Phase 1

Completed

Conditions: HIV/AIDS

Interventions: Drug: Maraviroc 300 mg tablet (PO) and Maraviroc 1% gel (PR and PV)

First Posted Date: 2015-01-26

Last Posted Date: 2017-09-08

Lead Sponsor: International Partnership for Microbicides, Inc.

Target Recruit Count: 19

Registration Number: NCT02346084

Locations: 🇺🇸
Magee Women's Hospital of UPMC, Pittsburgh, Pennsylvania, United States

Study of Dapivirine Vaginal Ring (VR) in Adolescents

Phase 2

Completed

Conditions: Human Immunodeficiency Virus

Interventions: Combination Product: placebo ring
Combination Product: dapivirine ring

First Posted Date: 2014-01-07

Last Posted Date: 2022-10-24

Lead Sponsor: International Partnership for Microbicides, Inc.

Target Recruit Count: 96

Registration Number: NCT02028338

Locations: 🇺🇸
University of Pittsburgh CRS, 3601 fifth Ave, Room 737, Pittsburgh, Pennsylvania, United States
🇺🇸
Alabama CRS 84519th street south, BBRB 203A, Birmingham, Alabama, United States
🇺🇸
The Fenway Institute, 1340 Boylston Street, Boston, Massachusetts, United States

and more 8 locations

Safety and Pharmacokinetics of Dapivirine Vaginal Ring in Post-menopausal Women

Phase 2

Completed

Conditions: Human Immunodeficiency Virus

Interventions: Drug: Dapivirine Vaginal Ring
Drug: Placebo Vaginal Ring

First Posted Date: 2013-12-13

Last Posted Date: 2022-11-03

Lead Sponsor: International Partnership for Microbicides, Inc.

Target Recruit Count: 96

Registration Number: NCT02010593

Locations: 🇺🇸
Magee Women's Hospital of UPMC, Pittsburgh, Pennsylvania, United States
🇺🇸
Case CRS, Case Western Reserve University, 2061 Cornell Road, Room 303, Cleveland, Ohio, United States
🇺🇸
Alabama CRS, 84519th Street South, BBRB 203A, Birmingham, Alabama, United States

Expanded Use PK of Dapivirine Vaginal Ring

Phase 1

Completed

Conditions: Pharmacokinetics

Interventions: Drug: dapivirine ring

First Posted Date: 2013-09-30

Last Posted Date: 2016-08-26

Lead Sponsor: International Partnership for Microbicides, Inc.

Target Recruit Count: 40

Registration Number: NCT01952561

PK/PD of Single Dose Dapivirine Vaginal Film

Phase 1

Completed

Conditions: Pharmaokinetics

Interventions: Drug: Dapivirine gel
Drug: Dapivirine film

First Posted Date: 2013-08-16

Last Posted Date: 2017-09-08

Lead Sponsor: International Partnership for Microbicides, Inc.

Target Recruit Count: 60

Registration Number: NCT01924091

Functionality of Male Condoms With a Silicone Elastomer Vaginal RIng

Phase 1

Completed

Conditions: Human Immunodeficiency Virus

Interventions: Combination Product: Placebo Vaginal Ring
Device: Condom

First Posted Date: 2012-12-24

Last Posted Date: 2018-03-29

Lead Sponsor: International Partnership for Microbicides, Inc.

Target Recruit Count: 70

Registration Number: NCT01755741

Locations: 🇺🇸
California Family Health Council, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy